Thank You for Joining Our Community!

We’re thrilled to welcome you as a new member of our journal. Your support helps advance scholarly research and ensures access to cutting-edge psychiatry articles and insights.

Personalize Your Experience

Help us customize your content and recommendations by verifying your professional credentials with your National Provider Identifier (NPI).

Note: You’ll need to log in or create an account to save your NPI information.

Do you have an NPI number?

Choose your interests

Select topics that interest you to receive personalized recommendations and content.

Our Recently Published Articles

PCC
Managing 7-hydroxymitragynine Withdrawal
Case Report

Managing 7-hydroxymitragynine Withdrawal

August 27, 2026

A 49-year-old man taking “7-OH” experienced significant opioid withdrawal symptoms that resolved with high-dose buprenorphine-naloxone treatment.
,
JCP
Obstetric Risk Associated with Stimulant vs Nonstimulant Treatment
Original Research

Obstetric Risk Associated with Stimulant vs Nonstimulant Treatment

August 26, 2026

Stimulant and nonstimulant use during pregnancy were both associated with increased risk for obstetric complications vs no medication.
,
JCP
ADHD Medication Safety in Pregnancy: Precise Estimates, Uncertain Causal Inference
Commentary

ADHD Medication Safety in Pregnancy: Precise Estimates, Uncertain Causal Inference

August 26, 2026

Comments on a recent study by Babinski and Tuan finding ADHD medication use predictive of adverse pregnancy outcomes.
JCP
The Prescriber’s Guide to Oral Ketamine for Depression
Clinical and Practical Psychopharmacology

The Prescriber’s Guide to Oral Ketamine for Depression

August 26, 2026

Explains clinical contexts in which oral ketamine can be used and presents a detailed protocol for the use of this intervention.
PCC
Generative AI in Mental Health
Rounds in the General Hospital

Generative AI in Mental Health

August 25, 2026

As patients rely more on generative AI to assess and manage symptoms, they may mistake its output for professional advice and be unable to gauge accuracy, quality, or biases.
, , , et al
PCC
Aripiprazole-Induced Hiccups
Case Report

Aripiprazole-Induced Hiccups

August 25, 2026

A 29-year-old man hospitalized for psychotic symptoms in the context of methamphetamine experienced persistent hiccups after starting aripiprazole.
, , , et al
JCP
SSRI Discontinuation and AUD Relapse
Case Report

SSRI Discontinuation and AUD Relapse

August 26, 2024

A man with AUD achieves sobriety on treatment with an SSRI and naltrexone, but then stops taking the SSRI to participate in a psilocybin “ceremony.” What factors contributed to…
, , , et al
JCP
Olanzapine and Mirtazapine for Cancer-Related Anorexia
Clinical and Practical Psychopharmacology

Olanzapine and Mirtazapine for Cancer-Related Anorexia

August 21, 2024

Dr Andrade discusses two RCTs that investigated the utility of olanzapine and mirtazapine in addressing appetite loss in cancer patients.
JCP
Functional Unblinding in Pivotal Studies and the Future of Psychedelic Medicine
Commentary

Functional Unblinding in Pivotal Studies and the Future of Psychedelic Medicine

August 21, 2024

Dr Rosenbaum comments on the challenge of evaluating trials of treatments whose effects are unmistakable, and how this dilemma may be addressed.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe